ZwickRoell to exhibit cutting-edge solutions for the testing of drug delivery devices at PDA 2018 conference

ZwickRoell will exhibit industry-leading solutions for the testing of drug delivery devices at the 2018 PDA Universe of Pre-Filled Syringes and Injection Devices to be held at the Loews Royal Pacific Resort at Universal Orlando, Orlando, Florida, October 8-10.

As part of the ZwickRoell Group, ZwickRoell in Atlanta offers a flexible, modular system of machines, specimen grips, and software that cover almost every segment in the medical industry, including drug delivery, medical and pharmaceutical packaging, surgical instruments and orthopedics. Visit booth #718 for demonstrations of our semi-automated autoinjector testing solution and torsion zwickiLine materials testing machine. Experts will be on hand to provide consultation and to discuss features of the testXpert III software that support compliance with 21 FDA CFR Part 11. We will also exhibit a wide variety of tooling that can be customized for unique testing applications.

In addition, ZwickRoell in Atlanta will exhibit testing solutions at Table 13 on October 10 at the post-exhibition workshop. Industry experts will demonstrate tooling options for medical device testing and provide consultation for your complex testing requirements. Information about ZwickRoell’s DQ, IQ and OQ on-site qualification service in accordance with current guidelines will also be available.
“Our semi-automated autoinjector testing solution is truly unique in that it offers up to eight tests in one test sequence, which means shorter testing times and reliable test results due to minimized operator influence,” said Lorraine McLean, Medical Industry Manager for ZwickRoell in Atlanta. “Our torsion zwickiLine tabletop testing machine with Fmax 2.5 kN and an additional torsion drive is an ideal solution for medical packaging and devices tested by a rotary movement with superimposed axial loading.”

PDA
Companies in the medical and pharmaceutical industries are faced with ever-increasing demands to document the traceability of completed actions. With the testXpert III software traceability option, users can log all actions and changes before, during, and after the test, making test results and documentation traceable and protecting them from manipulation. Integrated user management and functions such as electronic records and electronic signature ensure that test results are tamper-proof. Together with organizational measures and procedure instructions that apply to the individual companies themselves, requirements of FDA in 21 CFR Part 11 are fulfilled.

Further information on ZwickRoell testing solutions for medical devices may be found here: www.zwickusa.com/medical
Top